Plasma Proteome Profiling to Assess Human Health and Disease

Cell Systems

Volumn 2, Issue 3, 2016, Pages 185-195

  Geyer, Philipp E ^a,b   Kulak, Nils A ^a   Pichler, Garwin ^a   Holdt, Lesca M ^c   Teupser, Daniel ^c   Mann, Matthias ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

apolipoproteins; blood analysis; clinic; disease; human; mass spectrometry; plasma proteome profile

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PLASMA PROTEIN; PROTEIN; PROTEOME;

ARTICLE; ASSESSMENT OF HUMANS; CONTROLLED STUDY; DISEASE ASSESSMENT; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEOMICS; TANDEM MASS SPECTROMETRY; GENE EXPRESSION PROFILING; MASS SPECTROMETRY;

BIOMARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION PROFILING; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84962173691     PISSN: 24054712     EISSN: 24054720     Source Type: Journal    
DOI: 10.1016/j.cels.2016.02.015     Document Type: Article

References (47)

1. T.A. Addona, X. Shi, H. Keshishian, D.R. Mani, M. Burgess, M.A. Gillette, K.R. Clauser, D. Shen, G.D. Lewis, L.A. Farrell, and et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease Nat. Biotechnol. 29 2011 635 643
2. N.L. Anderson The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum Clin. Chem. 56 2010 177 185
3. L. Anderson Six decades searching for meaning in the proteome J. Proteomics 107 2014 24 30
4. N.L. Anderson, and N.G. Anderson The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 1 2002 845 867
5. N.L. Anderson, N.G. Anderson, T.W. Pearson, C.H. Borchers, A.G. Paulovich, S.D. Patterson, M. Gillette, R. Aebersold, and S.A. Carr A human proteome detection and quantitation project Mol. Cell. Proteomics 8 2009 883 886
6. J.P. Bai, J.S. Barrett, G.J. Burckart, B. Meibohm, H.C. Sachs, and L. Yao Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants AAPS J. 15 2013 447 454
7. E. Bellei, S. Bergamini, E. Monari, L.I. Fantoni, A. Cuoghi, T. Ozben, and A. Tomasi High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins Amino Acids 40 2011 145 156
8. Z. Cao, H.Y. Tang, H. Wang, Q. Liu, and D.W. Speicher Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes J. Proteome Res. 11 2012 3090 3100
9. U. Christensen, M. Simonsen, N. Harrit, and L. Sottrup-Jensen Pregnancy zone protein, a proteinase-binding macroglobulin. Interactions with proteinases and methylamine Biochemistry 28 1989 9324 9331
10. J. Cox, and M. Mann MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 26 2008 1367 1372
11. J. Cox, and M. Mann Quantitative, high-resolution proteomics for data-driven systems biology Annu. Rev. Biochem. 80 2011 273 299
12. J. Cox, and M. Mann 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data BMC Bioinformatics 13 Suppl 16 2012 S12
13. J. Cox, N. Neuhauser, A. Michalski, R.A. Scheltema, J.V. Olsen, and M. Mann Andromeda: a peptide search engine integrated into the MaxQuant environment J. Proteome Res. 10 2011 1794 1805
14. J. Cox, M.Y. Hein, C.A. Luber, I. Paron, N. Nagaraj, and M. Mann Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ Mol. Cell. Proteomics 13 2014 2513 2526
15. F. Edfors, T. Boström, B. Forsström, M. Zeiler, H. Johansson, E. Lundberg, S. Hober, J. Lehtiö, M. Mann, and M. Uhlen Immunoproteomics using polyclonal antibodies and stable isotope-labeled affinity-purified recombinant proteins Mol. Cell. Proteomics 13 2014 1611 1624
16. T. Farrah, E.W. Deutsch, G.S. Omenn, Z. Sun, J.D. Watts, T. Yamamoto, D. Shteynberg, M.M. Harris, and R.L. Moritz State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project J. Proteome Res. 13 2014 60 75
17. T. Geiger, J. Cox, and M. Mann Proteomics on an Orbitrap benchtop mass spectrometer using all-ion fragmentation Mol. Cell. Proteomics 9 2010 2252 2261
18. S. Hua, C. Song, C.L. Geczy, S.B. Freedman, and P.K. Witting A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis Redox Rep. 14 2009 187 196
19. A.J. Jenkins, P.P. Toth, and T.J. Lyons Lipoproteins in Diabetes Mellitus 2014 Humana Press
20. M.K. Jensen, M.L. Bertoia, L.E. Cahill, I. Agarwal, E.B. Rimm, and K.J. Mukamal Novel metabolic biomarkers of cardiovascular disease Nat. Rev. Endocrinol. 10 2014 659 672
21. C.D. Kelstrup, R.R. Jersie-Christensen, T.S. Batth, T.N. Arrey, A. Kuehn, M. Kellmann, and J.V. Olsen Rapid and deep proteomes by faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap mass spectrometer J. Proteome Res. 13 2014 6187 6195
22. H. Keshishian, M.W. Burgess, M.A. Gillette, P. Mertins, K.R. Clauser, D.R. Mani, E.W. Kuhn, L.A. Farrell, R.E. Gerszten, and S.A. Carr Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury Mol. Cell. Proteomics 14 2015 2375 2393
23. B. Krastins, A. Prakash, D.A. Sarracino, D. Nedelkov, E.E. Niederkofler, U.A. Kiernan, R. Nelson, M.S. Vogelsang, G. Vadali, A. Garces, and et al. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum Clin. Biochem. 46 2013 399 410
24. N.A. Kulak, G. Pichler, I. Paron, N. Nagaraj, and M. Mann Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells Nat. Methods 11 2014 319 324
25. Y. Liu, A. Buil, B.C. Collins, L.C. Gillet, L.C. Blum, L.Y. Cheng, O. Vitek, J. Mouritsen, G. Lachance, T.D. Spector, and et al. Quantitative variability of 342 plasma proteins in a human twin population Mol. Syst. Biol. 11 2015 786
26. E. Martínez-Morillo, H.M. Nielsen, I. Batruch, A.P. Drabovich, I. Begcevic, M.F. Lopez, L. Minthon, G. Bu, N. Mattsson, E. Portelius, and et al. Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms J. Proteome Res. 13 2014 1077 1087
27. J. Muñoz, and A.J. Heck From the human genome to the human proteome Angew. Chem. Int. Ed. Engl. 53 2014 10864 10866
28. N. Nagaraj, N.A. Kulak, J. Cox, N. Neuhauser, K. Mayr, O. Hoerning, O. Vorm, and M. Mann System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap Mol. Cell. Proteomics 11 2012 M111.013722
29. V. Nanjappa, J.K. Thomas, A. Marimuthu, B. Muthusamy, A. Radhakrishnan, R. Sharma, A. Ahmad Khan, L. Balakrishnan, N.A. Sahasrabuddhe, S. Kumar, and et al. Plasma Proteome Database as a resource for proteomics research: 2014 update Nucleic Acids Res. 42 2014 D959 D965
30. G.S. Omenn Exploring the Human Plasma Proteome Volume 5 2005 John Wiley
31. U.B. Ottosson, J.E. Damber, M.G. Damber, G. Selstam, F. Solheim, T. Stigbrand, R. Södergård, and B. von Schoultz Effects of sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyl-oestradiol and norethisterone Maturitas 3 1981 295 300
32. S. Paczesny, T.M. Braun, J.E. Levine, J. Hogan, J. Crawford, B. Coffing, S. Olsen, S.W. Choi, H. Wang, V. Faca, and et al. Elafin is a biomarker of graft-versus-host disease of the skin Sci. Transl. Med. 2 2010 13ra2
33. O. Sand, J. Folkersen, J.G. Westergaard, and L. Sottrup-Jensen Characterization of human pregnancy zone protein. Comparison with human alpha 2-macroglobulin J. Biol. Chem. 260 1985 15723 15735
34. C. Schaab, T. Geiger, G. Stoehr, J. Cox, and M. Mann Analysis of high accuracy, quantitative proteomics data in the MaxQB database Mol. Cell. Proteomics 11 2012 M111.014068
35. R.A. Scheltema, and M. Mann SprayQc: a real-time LC-MS/MS quality monitoring system to maximize uptime using off the shelf components J. Proteome Res. 11 2012 3458 3466
36. R.A. Scheltema, J.P. Hauschild, O. Lange, D. Hornburg, E. Denisov, E. Damoc, A. Kuehn, A. Makarov, and M. Mann The Q Exactive HF, a Benchtop mass spectrometer with a pre-filter, high-performance quadrupole and an ultra-high-field Orbitrap analyzer Mol. Cell. Proteomics 13 2014 3698 3708
37. G. Such-Sanmartín, E. Ventura-Espejo, and O.N. Jensen Depletion of abundant plasma proteins by poly(N-isopropylacrylamide-acrylic acid) hydrogel particles Anal. Chem. 86 2014 1543 1550
38. K. Suhre, S.Y. Shin, A.K. Petersen, R.P. Mohney, D. Meredith, B. Wägele, E. Altmaier, P. Deloukas, J. Erdmann, E. Grundberg, et al. CARDIoGRAM Human metabolic individuality in biomedical and pharmaceutical research Nature 477 2011 54 60
39. S. Surinova, R. Schiess, R. Hüttenhain, F. Cerciello, B. Wollscheid, and R. Aebersold On the development of plasma protein biomarkers J. Proteome Res. 10 2011 5 16
40. R.E. Tanzi The genetics of Alzheimer disease Cold Spring Harb. Perspect. Med. 2 2012 2
41. A. Thompson, J. Schäfer, K. Kuhn, S. Kienle, J. Schwarz, G. Schmidt, T. Neumann, R. Johnstone, A.K. Mohammed, and C. Hamon Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS Anal. Chem. 75 2003 1895 1904
42. C. Tu, P.A. Rudnick, M.Y. Martinez, K.L. Cheek, S.E. Stein, R.J. Slebos, and D.C. Liebler Depletion of abundant plasma proteins and limitations of plasma proteomics J. Proteome Res. 9 2010 4982 4991
43. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine Guidance for Industry, Bioanalytical Method Validation 2001 U.S. Department of Health and Human Services
44. A. Végvári, C. Welinder, H. Lindberg, T.E. Fehniger, and G. Marko-Varga Biobank resources for future patient care: developments, principles and concepts J. Clin. Bioinforma. 1 2011 24
45. P. Vihko, E. Sajanti, O. Jänne, L. Peltonen, and R. Vihko Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay Clin. Chem. 24 1978 1915 1919
46. P.W. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr., and C.J. O'Donnell C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes 1 2008 92 97
47. M. Zeiler, W.L. Straube, E. Lundberg, M. Uhlen, and M. Mann A protein epitope signature tag (PrEST) library allows SILAC-based absolute quantification and multiplexed determination of protein copy numbers in cell lines Mol. Cell. Proteomics MCP 11 2012 O111.009613